UAE says Sinopharm generated coronavirus antibodies in 96% of children

August 11, 2021 | 16:40 GST The vaccine was approved for use in children aged 3 to 17 after a trial involving 900 young people. Officials set out the initial results of Abu Dhabi-based studies at a televised briefing on Tuesday evening. There were no negative side effects among children who received the vaccine, other than … Continue reading UAE says Sinopharm generated coronavirus antibodies in 96% of children